Invest Now
Samco Star Rating Ads

Jagsonpal Pharmaceuticals Ltd Price Performance

  • Day's Low
  • ₹683.1
  • Day's High
  • ₹729.95
₹ 688.05
  • 52-w low
  • ₹273.6
  • 52-w high
  • ₹820.1
688.05
  • Day's open
    ₹720.5
  • Previous close
    ₹713.5
  • VWAP
    ₹703.94
  • Lower price band
    ₹570.8
  • Upper price band
    ₹856.2

Today's Market Action

The last traded share price of Jagsonpal Pharmaceuticals Ltd was 688.05 down by -3.57% on the NSE. Its last traded stock price on BSE was 688.00 down by -3.53%. The total volume of shares on NSE and BSE combined was 93,935 shares. Its total combined turnover was Rs 6.61 crores.

Jagsonpal Pharmaceuticals Ltd Medium and Long Term Market Action

Jagsonpal Pharmaceuticals Ltd hit a 52-week high of 820.1 on 29-11-2024 and a 52-week low of 273.6 on 27-03-2024. The stock price of Jagsonpal Pharmaceuticals Ltd is up by 17% over the last one month. It is up by 72.88% over the last one year. Don't forget to check the full stock price history in the table below.

Jagsonpal Pharmaceuticals Ltd Fundamentals

  • Market Cap (Cr): 1413

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Jagsonpal Pharmaceuticals Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Jagsonpal Pharmaceuticals Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Jagsonpal Pharmaceuticals Ltd

Data not available.

Jagsonpal Pharmaceuticals Ltd FAQ's

What is Share Price of Jagsonpal Pharmaceuticals Ltd?

What is the Market Cap of Jagsonpal Pharmaceuticals Ltd?

What is PE Ratio of Jagsonpal Pharmaceuticals Ltd?

What is PB Ratio of Jagsonpal Pharmaceuticals Ltd?

What is the CAGR of Jagsonpal Pharmaceuticals Ltd?

How to Buy Jagsonpal Pharmaceuticals Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 106.06% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.05. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Negative Margin of Safety
    The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(19/12/2024)
Stock Valuation
Red line
78
100.00%
100.00% People are bullish about Jagsonpal Pharmaceuticals Ltd
0.00%
0.00 % People are bearish about Jagsonpal Pharmaceuticals Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Jagsonpal Pharmaceuticals Ltd

688.05 -25.45 (-3.57%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91